ArticleBMC genomics2026
Hybrid genome assembly and comprehensive genomic analysis of Lactiplantibacillus pentosus LP309 reveal its probiotic and technological potential.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gene Exchange Mechanisms in Natural and Engineered Probiotics Within the Human Gut Implications for Antibiotic Resistance and Metabolic Modulation.Probiotics and antimicrobial proteins · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study provides an in-depth genomic and functional characterization of Lactiplantibacillus pentosus LP309, a strain isolated from table olive fermentations. The microorganism was sequenced using three next‑generation sequencing platforms—Illumina, PacBio, and Oxford Nanopore Technologies (ONT)—and multiple assembly and polishing strategies were evaluated. Assembly performance and annotation quality metrics were compared across approaches, and the most complete hybrid assembly for this study (Illumina + ONT) was selected for comprehensive genomic characterization.
resultsThe complete chromosome was circularized at 3,523,074 bp, and together with eight plasmids, the total genome length reached 3,743,370 bp, comprising 3,448 coding sequences (CDSs) and reflecting the genomic complexity of LP309 strain. Taxonomic assignment based on Average Nucleotide Identity confirmed the species identity, while functional annotation predicted the presence of two bacteriocin and two exopolysaccharide biosynthesis clusters. Additionally, over 150 genes related to the probiotic and technological potential of the strain were also identified, including those involved in adhesion, acid stress resistance, vitamin biosynthesis, and carbohydrate metabolism, among others. Safety assessment confirmed the absence of genes associated with virulence, antibiotic or acquired antimicrobial resistance. Mobilome analysis revealed four prophages, 133 insertion sequences, and four genomic islands, while no integrons were detected.
conclusionsThis in silico study has revealed the strong technological relevance and probiotic potential of LP309, establishing this plant-based bacterium as a safe and functionally versatile candidate for applications in the food and biotechnology industries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.